(Q37579935)

https://api.crossref.org/works/10.1042%2FCS20080659

Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Abdominal muscle and quadriceps strength in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Quadriceps Fatigability after Single Muscle Exercise in Patients with Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Physiological properties of human diaphragm muscle fibres and the effect of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Inspiratory and skeletal muscle strength and endurance and diaphragmatic activation in patients with chronic airflow limitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Maximal force and endurance to fatigue of respiratory and skeletal muscles in chronic hypoxemic patients: the effects of oxygen breathing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Characteristics of physical activities in daily life in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

A novel technique for nonvolitional assessment of quadriceps muscle endurance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Inspiratory pressure support prolongs exercise induced lactataemia in severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Skeletal muscle metabolism during exercise and recovery in patients with respiratory failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Uncoupling protein-3 content is decreased in peripheral skeletal muscle of patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Bioenergetic adaptation of individual human diaphragmatic myofibers to severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Effect of chronic hypoxia on muscle enzyme activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Elevated inosine monophosphate levels in resting muscle of patients with stable chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Weakness of respiratory and skeletal muscles after a short course of steroids in patients with acute lung rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Catabolic/anabolic balance and muscle wasting in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

From muscle disuse to myopathy in COPD: potential contribution of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

The contribution of genetic influences to measures of lower-extremity function in older male twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Evaluation of a movement detector to measure daily activity in patients with chronic lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Lower limb activity and its determinants in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Risk factors of readmission to hospital for a COPD exacerbation: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Regulation of eIF-4E BP1 phosphorylation by mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

GSK-3beta negatively regulates skeletal myotube hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Patterns of gene expression in atrophying skeletal muscles: response to food deprivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Identification of ubiquitin ligases required for skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Activation of an alternative NF-kappaB pathway in skeletal muscle during disuse atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

IKKbeta/NF-kappaB activation causes severe muscle wasting in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Myostatin mutation associated with gross muscle hypertrophy in a child

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Effects of rehabilitative exercise on peripheral muscle TNFalpha, IL-6, IGF-I and MyoD expression in patients with COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

AMPK and PPARdelta agonists are exercise mimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Genetic Influences on Muscle Strength, Lean Body Mass, and Bone Mineral Density: A Twin Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659

Morphological adaptations of human skeletal muscle to chronic hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080659